Barclays PLC Iradimed Corp Transaction History

Barclays PLC

$288 Billion
Q1 2024

A detailed history of Barclays PLC transactions in Iradimed Corp stock. As of the latest transaction made, Barclays PLC holds 14,752 shares of IRMD stock, worth $648,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,752

Previous 19,518 24.42%

Holding current value

$648,202

Previous $926,000 29.91%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$41.17 - $47.29 $196,216 - $225,384	-4,766 Reduced 24.42%	14,752 $649,000
Q4 2023 Feb 15, 2024	BUY	$37.31 - $47.47 $330,641 - $420,679	8,862 Added 83.16%	19,518 $926,000
Q3 2023 Nov 07, 2023	BUY	$43.28 - $50.3 $138,625 - $161,110	3,203 Added 42.98%	10,656 $472,000
Q2 2023 Aug 03, 2023	SELL	$38.88 - $50.61 $79,665 - $103,699	-2,049 Reduced 21.56%	7,453 $356,000
Q1 2023 May 04, 2023	BUY	$28.48 - $42.14 $52,858 - $78,211	1,856 Added 24.27%	9,502 $374,000

Q4 2022 Feb 13, 2023	BUY	$26.9 - $30.58 $69,590 - $79,110	2,587 Added 51.14%	7,646 $216,000
Q3 2022 Nov 03, 2022	SELL	$29.42 - $42.25 $1,647 - $2,366	-56 Reduced 1.09%	5,059 $152,000
Q2 2022 Aug 12, 2022	SELL	$30.15 - $45.79 $400,180 - $607,770	-13,273 Reduced 72.18%	5,115 $173,000
Q1 2022 May 16, 2022	BUY	$36.01 - $53.14 $155,167 - $228,980	4,309 Added 30.61%	18,388 $825,000
Q4 2021 Feb 14, 2022	BUY	$32.35 - $48.27 $165,114 - $246,370	5,104 Added 56.87%	14,079 $650,000
Q3 2021 Nov 09, 2021	BUY	$29.5 - $37.21 $52,834 - $66,643	1,791 Added 24.93%	8,975 $301,000
Q2 2021 Aug 13, 2021	SELL	$24.04 - $29.79 $98,972 - $122,645	-4,117 Reduced 36.43%	7,184 $212,000
Q1 2021 May 13, 2021	BUY	$22.3 - $26.02 $36,594 - $42,698	1,641 Added 16.99%	11,301 $290,000
Q4 2020 Feb 11, 2021	SELL	$20.62 - $25.0 $10,495 - $12,725	-509 Reduced 5.01%	9,660 $220,000
Q3 2020 Nov 12, 2020	SELL	$21.0 - $24.61 $57,813 - $67,751	-2,753 Reduced 21.3%	10,169 $216,000
Q2 2020 Aug 12, 2020	BUY	$18.68 - $24.35 $159,770 - $208,265	8,553 Added 195.77%	12,922 $299,000
Q1 2020 May 13, 2020	SELL	$16.08 - $27.67 $48,127 - $82,816	-2,993 Reduced 40.65%	4,369 $93,000
Q4 2019 Feb 10, 2020	BUY	$21.11 - $25.92 $42,431 - $52,099	2,010 Added 37.56%	7,362 $171,000
Q3 2019 Nov 14, 2019	BUY	$18.06 - $24.1 $45,312 - $60,466	2,509 Added 88.25%	5,352 $113,000
Q2 2019 Aug 14, 2019	SELL	$19.6 - $29.31 $1,038 - $1,553	-53 Reduced 1.83%	2,843 $58,000
Q1 2019 May 15, 2019	BUY	$23.58 - $28.43 $19,736 - $23,795	837 Added 40.65%	2,896 $82,000
Q4 2018 Feb 14, 2019	BUY	$20.63 - $34.04 $14,874 - $24,542	721 Added 53.89%	2,059 $50,000
Q3 2018 Nov 14, 2018	BUY	$20.6 - $37.15 $4,882 - $8,804	237 Added 21.53%	1,338 $50,000
Q2 2018 Aug 14, 2018	BUY	$14.15 - $20.75 $15,381 - $22,555	1,087 Added 7764.29%	1,101 $24,000
Q1 2018 May 15, 2018	BUY	$13.0 - $15.8 $182 - $221	14 New	14 $0

Others Institutions Holding IRMD

# of Institutions

127

Shares Held

6.75M

Call Options Held

7.7K

Put Options Held

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $552M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account